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Abstract
Polycystic ovary syndrome (PCOS) is prevalent in reproductive-aged women and confounded by metabolic morbidities,
including insulin resistance and type 2 diabetes. Although the etiology of PCOS is undefined, contribution of prenatal
androgen (PA) exposure has been proposed in a rhesus monkey model as premenopausal PA female adults have PCOS-like
phenotypes in addition to insulin resistance and decreased glucose tolerance. PA female infants exhibit relative
hyperinsulinemia, suggesting prenatal sequelae of androgen excess on glucose metabolism and an antecedent to future
metabolic disease. We assessed consequences of PA exposure on pancreatic islet morphology to identify evidence of
programming on islet development. Islet counts and size were quantified and correlated with data from intravenous
glucose tolerance tests (ivGTT) obtained from dams and their offspring. Average islet size was decreased in PA female
infants along with corresponding increases in islet number, while islet fractional area was preserved. Infants also
demonstrated an increase in both the proliferation marker Ki67 within islets and the beta to alpha cell ratio suggestive of
enhanced beta cell expansion. PA adult females have reduced proportion of small islets without changes in proliferative or
apoptotic markers, or in beta to alpha cell ratios. Together, these data suggest in utero androgen excess combined with
mild maternal glucose intolerance alter infant and adult islet morphology, implicating deviant islet development. Marked
infant, but subtle adult, morphological differences provide evidence of islet post-natal plasticity in adapting to changing
physiologic demands: from insulin sensitivity and relative hypersecretion to insulin resistance and diminished insulin
response to glucose in the mature PCOS-like phenotype.
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Introduction
Polycystic ovary syndrome (PCOS) is one of the most prevalent
endocrine and metabolic disorders in reproductive-aged women,
but its etiology is still not understood. PCOS frequently becomes
symptomatic in adolescence and has a heterogeneous phenotype,
requiring at least two of the following three criteria for diagnosis:
hyperandrogenism, oligo-anovulation, and/or ultrasonographic
evidence of polycystic ovaries [1]. Other associated physiologic
and metabolic abnormalities often include gestational diabetes,
impaired glucose tolerance, hyperinsulinemia and type 2 diabetes
mellitus, making women with PCOS at significant risk of increased
morbidity and mortality [2].
Studies with nonhuman primates (NHP), sheep, rats and mice
have suggested an epigenetic mechanism for PCOS based upon
in utero exposure of the developing female fetus to androgen
excess and associated metabolic consequences [3,4,5,6]; a
hypothesis supported by evidence of an altered epigenome in
visceral adipose tissue from prenatally androgenized (PA) female
NHP [7,8]. Female rhesus monkeys exposed to prenatal androgen
excess have shown the most comprehensive adult PCOS-like
phenotype, meeting all three diagnostic criteria in addition to the
metabolic comorbidities of insulin resistance, impaired pancreatic
beta cell function and increased prevalence of type 2 diabetes
mellitus [4]. Interestingly, this adult metabolic phenotype is
preceded by excessive insulin sensitivity, increased insulin secretion
relative to insulin sensitivity in infancy and increased rapidity of
glucose clearance [9].
Such endocrine antecedents of glucose homeostasis in infant PA
female rhesus monkeys suggest that experimentally-induced fetal
androgen excess may differentially program insulin action and
secretion in infancy, preceding the onset of later adult metabolic
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dysfunction. In support of this concept, pancreatic beta cell
development begins in early fetal life in rhesus monkeys [10]
during which time regulatory mechanisms governing islet mor-
phology and function may be susceptible to hormonal and
metabolic changes in utero, particularly since the primate
pancreas expresses androgen receptors [11,12]. In addition, as
androgen treatment of monkey dams also induces mild maternal
glucose intolerance and transient hyperglycemia in both dams and
PA female fetuses [9], quantifying changes in PA monkey islet
morphology may elucidate effects of both fetal excess androgen
exposure and accompanying fetal glucose dysregulation on islet
development, implying an epigenetic origin for abnormal glucose
regulation in this well-established, NHP model for PCOS.
The pattern of hyperinsulinism from offspring of diabetic
mothers follow by impaired glucose homeostasis is clinically well
characterized in humans and has been described before in rodent
models [13]. Given the similar pattern in the NHP model for
PCOS, we were interested in whether such altered glucoregulatory
function had morphological consequences for pancreatic islets in
PA monkeys. In this pilot study, we thus quantified pancreatic islet
morphology, as a marker for islet development in female monkeys
exposed to transient testosterone and mild maternal glucose
intolerance while in utero, looking for morphological alterations
that could be associated with abnormalities of glucose metabolism
measured by ivGTT. Given the relative hyperinsulinism of PA
monkey infants, we hypothesized that PA infants would demon-
strate morphologic changes consistent with islet hyperplasia in
response to in utero hyperglycemia from maternal androgen
treatment, similar to that seen in human offspring of diabetic
mothers [14]. We also anticipated finding morphometric ante-
cedents in the PA infant that carried forward into PA adult female
pancreatic dysfunction, such as decreased islet number or
fractional area providing a link between pancreatic islet develop-
ment and adult metabolic disease, as recently proposed to precede
type 2 diabetes mellitus in humans [15].
Results
Experiment 1: Infant morphology
Average islet size by Mann Whitney U-test was decreased (P,
0.05) in PA infants compared to controls (control 1105 (939, 1498);
PA 788 (520, 949) mm2), but was accompanied by a corresponding
increase (P,0.05) in islet numbers (control 2.27 (60.31); PA 3.94
(60.40)/mm261026) preserving fractional islet area (Figure 1a–c).
Analysis of the distribution of islet size demonstrated a greater
frequency of smaller islets in the PA group (P,0.001) (Figure 2a).
PA infants also showed an increased proportion of beta to alpha
cells (P,0.05; control 0.86 (60.12); PA 1.45 (60.19)), which
tended (P=0.056) to positively correlate with basal insulin levels
(Figure 3a–d). The morphologic data (i.e., islet fractional area, islet
count/section area, average islet size, and islet size distribution)
did not correlate with basal serum glucose or insulin levels, glucose
clearance (KG), insulin sensitivity, disposition index, (AUC)glucose,
nor with AUCinsulin of the gestational iv glucagon test during the
third trimester or the ivGTT at 45 days of life (data not shown).
Experiment 2: Adult morphology
In adulthood, PA female pancreatic sections, compared to
controls, showed a trend (P=0.067) towards reduced fraction of
small islets, ranging from 100 to 1100 mm2 in size (data not shown)
and decreased islet counts (P=0.068; control 8.25 (60.75); PA
6.11 (60.74))/mm261026) (data not shown). Although the PA
females did not otherwise differ in morphologic measurements
compared to controls the distribution of islet sizes demonstrated a
significant decrease in frequency of smaller islets (P,0.001)
(Figure 2b). In addition, PA adult pancreatic morphological and
ivGTT parameters demonstrated a positive correlation (P,0.05)
between average islet size versus AUCinsulin levels, and a trend
(P=0.058) towards a positive correlation with basal insulin
(Figure 4a–b), relationships that were absent in adult controls.
Apoptosis and proliferation markers
Although TUNEL cells were visualized in the exocrine tissue of
the pancreas, events within the islets were comparably rare in both
the infants and adults and did not differ significantly between PA
monkeys and respective controls. Apoptotic events in infant islets
Figure 1. A decrease in average islet area (P,0.05) (a) was
associated an increase in the islet count (P,0.05) (b) preserv-
ing the overall islet fractional area (c).
doi:10.1371/journal.pone.0106527.g001
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were observed in 3 out of 4 controls (median of 0.01 events/islet
area) and 1 out of 4 PA infants (0.01 events/islet area). In adults,
none of the 7 controls exhibited positive TUNEL staining within
the islets, while only 2 out of 6 PA adults showed apoptotic events
within islets (median 0.05 events/islet area).
The Ki67 marker for proliferation was seen in both the exocrine
tissue and within islets. The number of Ki67 positive cells within
islets was greater (P,0.01) in PA infants (6.2 (60.47)61024/mm2)
compared to controls (3.5 (60.49)61024/mm2) (Figure 5), while
the number of events in adults was low and did not differ between
treatment groups (adult control: 0.14 (60.043)61024/mm2, adult
PA: 0.15 (60.054)61024/mm2).
Discussion
While the data presented in this pilot study are constrained by
low animal numbers, an inherent problem in the use of NHP
models, our results are congruent with a growing body of evidence
that links altered fetal environment to adult metabolic disease,
specifically abnormal glucose regulation. TP-injected rhesus
monkey dams had a transient, postprandial hyperglycemic
maternal state, inducing a correspondingly hyperandrogenemic
and transient hyperglycemic intrauterine environment for female
fetuses [9]. As a metabolic consequence, PA offspring demon-
strated over-compensated insulin responses to glucose in infancy
[9] and we now demonstrate initial evidence for morphological
alterations in PA monkey pancreatic islets.
Experiment 1: Infants
The islet morphology changes in infant PA monkeys result from
a multi-factorial intrauterine exposure: namely, androgen excess
and hyperglycemia neither of which can be assessed independently
in these experiments, but both can be argued to play a potential
role in islet programming. [16] [17] [11,12,18].
The stimulatory effects of glucose on beta cell proliferation and
growth have been well reported [19,20]. Elevated glucose levels in
PA female fetal monkeys, from diminished maternal pancreatic
adaptation to pregnancy due to testosterone-induced insulin
resistance [9], may contribute to fetal beta cell proliferation. The
morphologic result of such a hyperglycemic gestational environ-
ment has been associated with beta cell hyperplasia and islet
hypertrophy similar to that seen in offspring of diabetic mothers
[14]. PA monkey infants in this study, however, have a smaller
average islet size. What apparently compensates for the lack of
observed islet expansion, as measured by islet fractional area, is
increased islet number that accompanies a greater proportion of
beta cells within each islet. Together, these findings are consistent
with a compensatory response of developing islets to increases in
glucose and testosterone exposure that results in increased
proliferation of islets containing a greater proportion of beta cells,
but with diminished overall size. Interpreting such PA infant
monkey pancreatic changes as a compensatory response to their
gestational environment is further supported by the positive
correlation between beta to alpha cell ratio and basal insulin levels
in PA infants, linking morphologic changes with physiologic
phenotype. The lack of difference between PA and control infants
with regard to TUNEL positive islet cells suggests a postnatal
adaptation of delayed or restricted expansion rather than a
destructive apoptotic process. Such plasticity of islet growth in
response to the glucose environment has been well described
[20,21,22]. Proliferation of small islets in PA infant monkeys,
however, may reflect a more primate-specific response to glycemic
challenge that may be analogous to human maternal small islet
proliferation in response to the glycemic challenge of pregnancy
[23], a response that is not emulated in rodents but may have some
relevance in PA female sheep [18].
In addition to the effects of glucose, there is also sufficient
evidence to support the pancreas as sex-steroid responsive [16,18].
The primate pancreas expresses androgen receptors [11,12],
allowing for a mechanism by which excessive androgen may
influence pancreatic development. And in vitro studies have
demonstrated impaired response to glucose in isolated islets
treated with testosterone [17]. Additionally, the PA ovine model
also confirms both the expression of androgen receptors in the fetal
pancreas as well altered islet development with fetal testosterone
exposure [18]. Examining the fetal pancreas from pregnant ewes
injected with testosterone, Rae and colleagues demonstrated
increased beta cell number and hypersecretion of insulin in the
female fetal pancreas. Interestingly, the dams were reported as
having normal glucose tolerance suggesting a direct role of
androgens separate from the effects of maternal glucose, but this
was not confirmed by direct fetal injections of androgen [6].
Figure 2. PA female infant islet size distribution is significantly
shifted towards an increase frequency of smaller islets
(P,0.001) (a) and the PA female adults are shifted towards a
higher frequency of larger islets (P,0.001) (b).
doi:10.1371/journal.pone.0106527.g002
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Experiment 2: Adults
Compared to controls, PA adult female monkeys demonstrate
impaired glucose regulation [24,25] and our current data
associates this pancreatic impairment with a positive correlation
between serum insulin levels and islet size, notably between
AUCinsulin or basal insulin levels and average islet size. Outside of
increased insulin production, how beta cells adapt to meet the
demands of diminished insulin sensitivity remains debated and is
the subject of ongoing research. Components of beta cell
neogenesis, hypertrophy, and increased replication have been
studied in several animal models and recently assessed during
human pregnancy; these studies have shown a state of normal, but
relative, insulin resistance [20,21,22,23]. Although adult PA
female monkeys exhibit a positive correlation between islet size
and basal or AUCinsulin, these insulin resistant, mildly glucose
intolerant adult PA females [25,26] demonstrate only subtle
morphological changes in the pancreas including loss of smaller
islets and decreased islet counts that are most pronounced by the
frequency of distribution data. Fractional area and ratio of beta to
alpha cells are comparable to adult female monkey controls, and
there is no evidence of increased apoptosis or proliferation to
suggest deficits in beta cell replication or turnover, respectively.
This altered size distribution despite maintenance of fractional islet
area, however, suggests reduced regenerative islet capacity
accompanies glucoregulatory impairment. Subtle PA monkey
pancreatic islet adaptation may thus result in PA monkey-specific
correlations between adult pancreatic islet morphology and basal
and glucose-stimulated circulating insulin levels. Both the shift
towards a distribution of larger islets and the correlation of
increasing islet size with increasing insulin levels in the PA female
adult monkeys suggest that in their hyperandrogenic, insulin
resistant state there are fewer but larger islets responsible for the
insulin production. This leads to the question of whether such
pathophysiology is a potential nidus for beta cell dysfunction and
eventual burnout and maybe analogous to a pre-diabetes state in
humans [15].
Although answering such inquiries will require further investi-
gation the identified discrete changes in infant and adult islet
morphology within these current experiments highlight important
impacts on islet development that are both congruent with prior
studies as well as novel in its applicability to human disease.
Murine studies have demonstrated severely limited beta cell
proliferation with advancing age [27,28]. The lack of increased
islet numbers in our hyperinsulinemic PA female adults illustrates
this as well; the adaptation to produce more insulin appears to
come from a distribution of larger islets rather than an increased
number or area. The almost complete absence of apoptosis in
these same pancreata, however, attests to the resilience and long
life-span of beta cells that has also been previously reported [29].
Additionally, our present study on altered PA monkey islet
morphology adds to the previous human findings that maternal
metabolic dysregulation imparts measurable outcomes in offspring
in regards to pancreatic morphology and function. Our data add
to the growing evidence supporting the clinical importance of
optimizing maternal metabolic health to prevent the programming
of future metabolic disease in the next generation.
Materials and Methods
Ethics statement
No live animal work was conducted in the current study.
Monkey pancreata harvested at both the California and Wisconsin
National Primate Research Centers (CNPRC (Experiments 1) and
WNPRC (Experiment 2), respectively) were stored at WNPRC
before processing for immunohistochemical analyses at both
WNPRC and Oregon Health Sciences University (OHSU). Some
of the adult pancreata were obtained through the WNPRC’s
Nonhuman Biological Material Distribution program. The
WNPRC principal investigator of the studies that originally
obtained the monkey pancreata (D.H. Abbott) gave permission
beta (blue) versus alpha (green) cell predominant islets of the PA infant (c) verses controls (b). Regression analysis demonstrates a trend for
correlation between increased relative beta cell mass and basal insulin levels (d).
doi:10.1371/journal.pone.0106527.g003
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Figure 3. PA female infant islets had an increase in their beta to alpha cell ratio (P  ,0.05).  (a) Immunofluorescent images representing the
for fellow authors to use harvested samples for this study. The care
and housing of, and harvesting of tissues from, female rhesus
monkeys (Macaca mulatta) at both the California and Wisconsin
National Primate Research Centers (CNPRC (Experiment 1) and
WNPRC (Experiment 2), respectively) were fully compliant with
the recommendations of the Guide for the Care and Use of
Laboratory Animals and the Animal Welfare Act. All procedures
were approved prior to implementation by the Institutional
Animal Care and Use Committees at the University of California,
Davis and the Graduate School, University of Wisconsin,
Madison.
Samples
Experiment 1 (CNPRC): Pancreata was assessed from a total of
nine female infants (,2 months of age). Five were born from dams
receiving 15 mg of testosterone propionate (TP) for 40 days
starting on day 40 of gestation [30], and four from control dams of
similar age and body weight receiving identically timed oil vehicle
injections (total N= 9). In both Experiments 1 and 2, the TP
dosing schedule elevated circulating testosterone levels in fetal
females to those typically found in fetal males during the early
stages of pancreatic organogenesis [4,30]. Female infants were
delivered by Cesarean-section at term (16062 days gestation) [30],
at which time body weight, crown-rump length, and assessments of
the placenta were found to be within normal limits [30]. The
infants were nursery reared using established methods for housing
and diet for this age group [31]. TP-treated dams showed mild-to-
moderate glucose intolerance during the second trimester (,80
days gestation; term 165610 days), while PA female infants at 45
days postnatal age showed increased insulin sensitivity and
disposition index [9]. The harvesting of infant pancreatic tissue
was accomplished following pre-medication with ketamine, at least
15 mg/kg injected intramuscularly, and induction of a deep plane
of anesthesia with an intravenous injection of barbiturate (25–
50 mg/kg) to effect (stoppage of the heart) prior to necropsy.
Experiment 2 (WNPRC): Pancreata from was assessed from
thirteen sexually mature, premenopausal female rhesus monkeys.
Six PA females were born from dams who received daily
subcutaneous (s.c.) injections of 10 mg TP for 15–35 days starting
at 4262 days gestation [4,32] and seven from untreated controls
of similar age and body weight (total N=13). Adult PA offspring
develop a PCOS-like phenotype, insulin resistance, and increased
incidence of type 2 diabetes mellitus, as previously reported
[24,33]. Prior to the current investigation, these adult females were
involved in a series of mechanistic studies, including [16,18,19,20].
The animals were fed Purina monkey chow (product no. 5038,
Ralston Purina, St Louis, MO, USA) twice daily and supplement-
ed with fresh fruit, vegetables and browse materials as part of the
environmental enrichment program. The formulation of monkey
chow provided 70% of calories as carbohydrate, 13% as fat, and
17% as protein, with a high fiber content. Adult females were pair
housed with an adult female conspecific in standard laboratory
housing (5.6 to 8.0 sq. ft.), unless incompatible with available
partners. The housing environments were maintained on a 12:12
Figure 4. PA adult female average islet size positively
correlates with AUCinsulin (a) and demonstrates a trend versus
basal insulin (b).
doi:10.1371/journal.pone.0106527.g004
Figure 5. Ki67-positive cells were increased (P,0.01) in the
exocrine (arrows) and endocrine tissue (arrow head) of controls (b) and
PA (c) infants.
doi:10.1371/journal.pone.0106527.g005
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islets of PA infants.  (a) Proliferative events were seen in both
light cycle, and were equipped with structural enhancements of
perches, toys and other manipulanda, providing ad libitum access
to water. Tissue harvests were performed as described for the
infants in Experiment 1 and tissue sections were evaluated from 6
PA premenopausal (menopause transition in rhesus monkeys, 26–
28 years of age [34]) adult females (age: 22.462.4 years, P,0.11
vs. controls; weight: 7.361.3 kg, P,0.013 vs. controls, mean6
SEM) and 7 adult female untreated controls (age: 19.463.4 years,
weight: 9.661.5 kg).
Glucoregulatory assessment
Glucoregulatory assessments were performed after overnight
fasts as previously reported on dams at 80 days of gestation, infants
at 45 postnatal days and on adults during the mid-to-late
reproductive years before menopause [9,24,25,35] (Table 1).
Basal insulin and glucose, insulin sensitivity (SI), disposition index
(DI), and area-under-the-curve for insulin (AUCinsulin) and glucose
(AUCglucose) were measured. TP-treated dams showed mild-to-
moderate glucose intolerance, while PA infants had increased
insulin sensitivity and disposition index [5]. In adulthood, the PA
group had decreased insulin sensitivity and disposition index [33].
There were no changes in fetal insulin and glucose responses to
glucagon challenge [9]. Although this data has been published
previously we have included a summary of the measured insulin
parameters referenced in our figures for our cohorts (Table 2).
Histology
Immunofluorescence study. Infant and adult pancreatic
tissues (from the tail region) obtained at harvest were stored at#2
80uC until processed for immunostaining. Two randomly selected
samples from each animal were thawed directly in 4% parafor-
maldehyde at 4uC and processed for paraffin embedding and
histologic sectioning by conventional methods. Each sample was
sectioned at 7 mm.
Two samples from each infant and adult monkey were
incubated overnight with rabbit anti-insulin polyclonal antibodies
at a 1:1000 dilution (#20056, Immunostar, Hudson, WI) and
guinea pig anti-glucagon polyclonal antibodies at a 1:7000 dilution
(#4031-01F, Linco, St. Charles, MO), after deparaffinization,
rehydration in serial ethanol washes, heat retrieval in citrate, and
blocking with 5% normal goat serum. Islets were visualized using
goat anti-rabbit 633 and goat anti-rabbit 488 at 1:500 dilutions
demarking the alpha and beta cells of the islets. Negative controls
were developed with the same protocol less the addition of the
primary antibodies. Six by six fields were imaged at 10X
magnification and tiled together to create one digital image using
the Nikon A1 confocal microscope which incorporated the entire
cross section of the sample. Image J was used to quantify total
section area (excluding attached connective tissue and large
vascular structures), islet count, and each islet area. Alpha and beta
mass was also quantified using Image J on the corresponding single
channel images.
The data obtained from both sections of each animal was
summed for semi-quantitative analysis. An average of 541 islets
were quantified for each adult and 813 from each infant. The
fractional area was calculated by dividing the total islet area (of all
islets combined for the relevant pancreatic section) by the total
area quantified for that section; the islet count was defined as total
number of islets per section area. Average islet size equaled the
total islet count divided by the total islet area. Cut off value for
smallest islets counted was set at 100 mm2 or greater to eliminate
two and three beta-cell aggregates.
ApopTag Fluorescein In Situ Apoptosis Detection Kit
(#S7110, Millipore, Temecula, CA) was used for quantification
of apoptosis in the islets using the manufactures protocol for
fluorescent staining of paraffin-embedded tissue. Sections were
double labeled with insulin using rabbit anti-insulin antibodies at
1:1000 (#20056, Immunostar, Hudson, WI) and goat anti-rabbit
secondary 633 (#A21071, Invitrogen) at 1:500 dilution to help
identify events that occurred within in the endocrine verses
exocrine tissue. Negative controls were developed with the same
protocol less the addition of the primary antibodies. Two sections
from each animal were imaged using laser-scanning confocal
microscope (Zeiss LSM710) at 20X. Twenty-five fields at this
magnification, arbitrarily starting at the gross center of the section,
were tiled together into one image using the Zeiss processing
software. The number of apoptotic events were manually counted
and divided by total surface area scanned using Image J. Mouse
monoclonal anti-human Ki67 (#M7240, Dako, Carpinteria, CA)
1:75 dilution was used to quantify proliferation events. Sections
were deparaffinized in xylene, rehydrated in serial washes of
ethanol, heat treated in citrate buffer and blocked using 5% bovine
serum antigen and 5% normal goat serum for one hour. The anti-
Ki67 antibody was incubated overnight at 4uC. Then visualized
using Vectastain Elite ABC peroxidase based detection system
using DAB (#PK-4002, Vector, Berlingame, CA). Sections were
subsequently incubated with the same insulin antibodies noted
above at 1:1000 overnight at 4uC and developed using Vectastain
ABC alkaline phosphatase detection kit (AK-5001) and Vector
Red (SK-5100) to help localized events to the endocrine tissue.
Negative controls were developed with the same protocol less the
addition of the primary antibodies. Digital images were taken
using Leica Application Suite V3.6 software under bright-field
microscopy at 20X on the Leica DFC340FX. Five random, non-
overlapping images containing at least one islet were quantified
from two different tissue samples for each animal. Like the
TUNEL assay, events were manually counted in Image J and
divided by quantified islet area.
Statistical evaluation
Islet fractional area and islet count were assessed using a two-
side t-test and a P value,0.05 as significant. Data were reported
as means (6 standard error of the mean (SEM)). Given that islet
size is not normally distributed, average islet size was analyzed by
non-parametric Mann-Whitney U testing and reported as median
Table 1. Composition of ivGTT by age.
ANIMAL AGE ivGTT COMPOSITION TOLBUTAMIDE (at 20 minutes)
Dams 80 days gestation 300 mg/kg glucose No
Infant 45 postnatal days 500 mg/kg glucose 20 mg/kg
Adult Premenopausal 300 mg/kg glucose 20 mg/kg
doi:10.1371/journal.pone.0106527.t001
Developmental Programming of Islet Morphology
PLOS ONE | www.plosone.org 6 September 2014 | Volume 9 | Issue 9 | e106527
(25%, 75% quartiles). Regressions illustrate the best fit line from a
data series representing the mean morphologic parameter of each
animal versus corresponding values for ivGTT (infant PA and
controls: postnatal day 45 [9]; dams of infant subjects: second
trimester, 80 days of gestation; adult PA females: 20.3 (61.4)
years; adult controls: 22.3 (61.0) years (mean (6SEM)) or for an iv
glucagon test (fetus: third trimester, 140 days of gestation [9]. The
empirical cumulative distribution function (ECDF) plotted for
each treatment and control group was constructed by the
probability of islets size being less than or equal to the given
value. The distributions of the islets were transformed using the
natural log transformation for visualization purposes (Figure 2).
Statistical analysis of the distribution data was performed using 2-
sample Kolmogorv-Smirnov test.
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